Publications by authors named "Jeffrey W Tyner"

100Publications

Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patients.

Oncotarget 2020 Jul 21;11(29):2807-2818. Epub 2020 Jul 21.

Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.27656DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381100PMC
July 2020

Keys to drug sensitivity from updated functional work flows.

Haematologica 2020 Jun;105(6):1468-1470

Division of Hematology and Medical Oncology

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2020.250662DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271592PMC
June 2020

Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy.

Leukemia 2020 06 16;34(6):1684-1688. Epub 2019 Dec 16.

Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0688-1DOI Listing
June 2020

What do functional genomics tell us about pathogenesis of AML?

Best Pract Res Clin Haematol 2019 12 18;32(4):101101. Epub 2019 Oct 18.

Knight Cancer Institute, Oregon Health & Science University, 2720 SW Moody Avenue, Portland, OR, 97201, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2019.101101DOI Listing
December 2019

Two myeloid leukemia cases with rare fusions.

Cold Spring Harb Mol Case Stud 2018 12 17;4(6). Epub 2018 Dec 17.

Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Knight Cancer Institute, Portland, Oregon 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a003079DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318770PMC
December 2018

Functional genomic landscape of acute myeloid leukaemia.

Nature 2018 10 17;562(7728):526-531. Epub 2018 Oct 17.

Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41586-018-0623-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280667PMC
October 2018

Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia.

Leukemia 2018 09 6;32(9):2025-2028. Epub 2018 Aug 6.

Department of Cell, Development & Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41375-018-0225-7
Publisher Site
http://dx.doi.org/10.1038/s41375-018-0225-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168939PMC
September 2018

ARID1A and CEBPα cooperatively inhibit UCA1 transcription in breast cancer.

Oncogene 2018 11 6;37(45):5939-5951. Epub 2018 Jul 6.

Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-018-0371-4DOI Listing
November 2018

Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL.

Oncogene 2018 09 30;37(38):5221-5232. Epub 2018 May 30.

Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-018-0299-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150818PMC
September 2018

Disparate effects of Shb gene deficiency on disease characteristics in murine models of myeloid, B-cell, and T-cell leukemia.

Tumour Biol 2018 Apr;40(4):1010428318771472

1 Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1010428318771472DOI Listing
April 2018

Automated decision tree to evaluate genetic abnormalities when determining prognostic risk in acute myeloid leukemia.

Haematologica 2018 08 22;103(8):e351-e355. Epub 2018 Mar 22.

Department of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, OR, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.190926DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068037PMC
August 2018

EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT.

Blood Adv 2017 Sep 28;1(20):1635-1644. Epub 2017 Aug 28.

Division of Hematology, Department of Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://www.bloodadvances.org/lookup/doi/10.1182/bloodadvance
Publisher Site
http://dx.doi.org/10.1182/bloodadvances.2017005694DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728330PMC
September 2017

DNA distress creates lethal opportunity in MPN.

Authors:
Jeffrey W Tyner

Blood 2017 12;130(26):2814-2816

OREGON HEALTH AND SCIENCE UNIVERSITY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-11-813006DOI Listing
December 2017

Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets.

J Hematol Oncol 2017 Nov 13;10(1):173. Epub 2017 Nov 13.

Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-017-0540-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683536PMC
November 2017

Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.

Curr Hematol Malig Rep 2017 10;12(5):432-441

Stanford Cancer Institute, Stanford University, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-017-0413-yDOI Listing
October 2017

Kinase Inhibitor Screening in Myeloid Malignancies.

Authors:
Jeffrey W Tyner

Hematol Oncol Clin North Am 2017 08 19;31(4):693-704. Epub 2017 May 19.

Department of Cell, Developmental and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, OHSU BRB 511, Mailcode L592, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2017.04.004DOI Listing
August 2017

Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function.

Cancer Res 2017 08 26;77(16):4258-4267. Epub 2017 Jun 26.

Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University Knight Cancer Institute, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-1052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763920PMC
August 2017

Turning the tide in myelodysplastic/myeloproliferative neoplasms.

Nat Rev Cancer 2017 06;17(7):425-440

INSERM U1170, Gustave Roussy, Faculté de médecine Paris-Sud, Université Paris-Saclay, F-94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc.2017.40DOI Listing
June 2017

PlGF enhances TLR-dependent inflammatory responses in human mononuclear phagocytes.

Am J Reprod Immunol 2017 Oct 20;78(4). Epub 2017 Jun 20.

Hematology and Medical Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/aji.12709DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915625PMC
October 2017

Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia.

Cell Rep 2017 03;18(13):3204-3218

Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2017.03.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437102PMC
March 2017

Identification of a Novel SYK/c-MYC/MALAT1 Signaling Pathway and Its Potential Therapeutic Value in Ewing Sarcoma.

Clin Cancer Res 2017 Aug 23;23(15):4376-4387. Epub 2017 Mar 23.

Department of Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2185DOI Listing
August 2017

Integrating functional genomics to accelerate mechanistic personalized medicine.

Authors:
Jeffrey W Tyner

Cold Spring Harb Mol Case Stud 2017 03;3(2):a001370

Department of Cell, Developmental and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a001370DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334473PMC
March 2017

Genomics of chronic neutrophilic leukemia.

Blood 2017 02 27;129(6):715-722. Epub 2016 Dec 27.

Knight Cancer Institute, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-10-695981DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301820PMC
February 2017

CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation.

Leuk Res 2017 02 12;53:39-49. Epub 2016 Dec 12.

Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR, USA; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2016.12.002DOI Listing
February 2017

Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Sci Transl Med 2016 08;8(354):354ra114

Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA. Division of Pediatric Hematology and Oncology, Doernbecher Children's Hospital, Oregon Health & Science University, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.aaf5309DOI Listing
August 2016

RNAi Screening of Leukemia Cells Using Electroporation.

Methods Mol Biol 2016 ;1470:85-94

Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-6337-9_7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240908PMC
December 2017

Ultrasensitive proteomic quantitation of cellular signaling by digitized nanoparticle-protein counting.

Sci Rep 2016 06 20;6:28163. Epub 2016 Jun 20.

Department of Biomedical Engineering, Oregon Health &Science University, Portland OR 97201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep28163DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913309PMC
June 2016

JAKed up phenotype of CEBPA-mutant AML.

Authors:
Jeffrey W Tyner

Blood 2016 06;127(24):2946-7

OREGON HEALTH & SCIENCE UNIVERSITY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-04-709535DOI Listing
June 2016

Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent.

J Hematol Oncol 2016 Mar 31;9:31. Epub 2016 Mar 31.

Center for Hematologic Malignancies, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-016-0258-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815159PMC
March 2016

Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia.

Cureus 2015 Dec 17;7(12):e414. Epub 2015 Dec 17.

Knight Cancer Institute, Oregon Health & Science University ; Howard Hughes Medical Institute Investigator Program, Howard Hughes Medical Institute ; Division of Hematology & Medical Oncology, Oregon Health & Science University ; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.414DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725740PMC
December 2015

What's different about atypical CML and chronic neutrophilic leukemia?

Hematology Am Soc Hematol Educ Program 2015 ;2015:264-71

Knight Cancer Institute, Department of Cell, Development and Cancer Biology, Oregon Health & Science University, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2015.1.264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266507PMC
October 2016

Therapeutically Targetable ALK Mutations in Leukemia.

Cancer Res 2015 Jun;75(11):2146-50

Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon. Department of Cell and Developmental Biology, Oregon Health and Science University, Portland, Oregon.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/75/11/2146.full.pd
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-14-1576DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453002PMC
June 2015

The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development.

Nat Cell Biol 2015 May 27;17(5):665-77. Epub 2015 Apr 27.

Departments of Physiology and Developmental Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncb3158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417000PMC
May 2015

Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer.

Mol Oncol 2015 Apr 15;9(4):889-905. Epub 2015 Jan 15.

Cancer Science Institute of Singapore, National University of Singapore, Singapore; Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA; National University Cancer Institute, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.01.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387089PMC
April 2015

Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance.

Cancer Res 2015 Mar 28;75(5):880-91. Epub 2014 Nov 28.

Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon. Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-0573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348216PMC
March 2015

Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia.

Leuk Res Rep 2014 1;3(2):67-9. Epub 2014 Aug 1.

Oregon Health and Sciences University, Knight Cancer Institute, Hematology and Medical Oncology, Portland, OR, USA ; Oregon Health and Sciences University, Knight Cancer Institute, Cell and Developmental Biology, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lrr.2014.07.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145163PMC
September 2014

Functional genomics for personalized cancer therapy.

Authors:
Jeffrey W Tyner

Sci Transl Med 2014 Jul;6(243):243fs26

Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3009586DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266503PMC
July 2014

Heterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomics.

Mol Cell Proteomics 2014 Nov 3;13(11):2803-11. Epub 2014 Jun 3.

From the ‡McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205; §Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205; ‖Department of Pathology, the Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/mcp.M114.038547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223473PMC
November 2014

PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma.

Proc Natl Acad Sci U S A 2014 Apr 14;111(17):6383-8. Epub 2014 Apr 14.

Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1403608111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035936PMC
April 2014

Functional integration of acute myeloid leukemia into the vascular niche.

Leukemia 2014 Oct 18;28(10):1978-1987. Epub 2014 Mar 18.

Oregon Stem Cell Center, Papé Family Pediatric Research Institute, Department of Pediatrics, Oregon Health & Sciences University, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/leu.2014.109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167983PMC
October 2014

TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling.

Database (Oxford) 2014 25;2014:bau007. Epub 2014 Feb 25.

McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD 21205, USA, Department of Biological Chemistry, Johns Hopkins University School of Medicine, 733 N. Broadway, Maryland, 21205, USA, Department of Oncology, Johns Hopkins University School of Medicine, 733 N. Broadway, Maryland, 21205, USA, Department of Pathology, Johns Hopkins University School of Medicine, 733 N. Broadway, Maryland, 21205, USA, Institute of Bioinformatics, International Technology Park, Bangalore 560066, India, Manipal University, Madhav Nagar, Manipal 576104, India, Centre of Excellence in Bioinformatics, School of Life Sciences, Pondicherry University, Puducherry 605014, India, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA, Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Mailcode L592, Portland, OR 97239, USA and Immunology Program, Benaroya Research Institute at Virginia Mason, 1201 9th Avenue S&C, Seattle, WA 98101, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/database/article-lookup/doi/10.1093
Publisher Site
http://dx.doi.org/10.1093/database/bau007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935308PMC
August 2014

Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia.

Clin Cancer Res 2014 Apr 16;20(8):2092-103. Epub 2014 Jan 16.

Authors' Affiliations: Knight Cancer Institute; Division of Hematology & Medical Oncology; Departments of Cell and Developmental Biology and Molecular and Medical Genetics, Oregon Health and Science University; Howard Hughes Medical Institute, Portland, Oregon; Oncotide Pharmaceuticals, Research Triangle Park; Duke University Medical Center, Durham, North Carolina; and Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/20/8/2092.full
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-2575DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989420PMC
April 2014

Causal role for JAK2 V617F in thrombosis.

Blood 2013 Nov;122(23):3705-6

UNIVERSITY OF CALIFORNIA, IRVINE;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-10-531665DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843232PMC
November 2013

Comparison of methods to identify aberrant expression patterns in individual patients: augmenting our toolkit for precision medicine.

Genome Med 2013 29;5(11):103. Epub 2013 Nov 29.

Knight Cancer Institute, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA ; Oregon Clinical and Translational Research Institute, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA ; Division of Bioinformatics and Computational Biology, DMICE, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gm509DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971350PMC
May 2014

Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins.

Proc Natl Acad Sci U S A 2013 Nov 11;110(48):19519-24. Epub 2013 Nov 11.

Knight Cancer Institute, Howard Hughes Medical Institute, and Departments of Biochemistry and Molecular Biology and Cell and Developmental Biology, Oregon Health and Sciences University, Portland, OR 97239.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1319583110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845150PMC
November 2013

ROR1 Flow Cytometry.

Bio Protoc 2013 Sep;3(18)

Cell, Developmental and Cancer Biology Department, Oregon Health and Science University, Portland, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957942PMC
http://dx.doi.org/10.21769/bioprotoc.905DOI Listing
September 2013